Effects of calcium and vitamin D3 on transforming growth factors in rectal mucosa of sporadic colorectal adenoma patients: A randomized controlled trial

Molecular Carcinogenesis

Volumn 54, Issue 4, 2015, Pages 270-280

  Tu, Huakang ^a,b   Flanders, W Dana ^a,b   Ahearn, Thomas U ^b   Daniel, Carrie R ^c   Gonzalez Feliciano, Amparo G ^a   Long, Qi ^a,b   Rutherford, Robin E ^d   Bostick, Roberd M ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium; Colorectal neoplasms; Transforming growth factor alpha (TGF ); Transforming growth factor beta 1 (TGF 1); Vitamin D3

Indexed keywords

CALCIUM CARBONATE; COLECALCIFEROL; PLACEBO; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1; ANTINEOPLASTIC AGENT; CALCIUM INTAKE; TRANSFORMING GROWTH FACTOR;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; COLORECTAL ADENOMA; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RECTUM MUCOSA; VITAMIN SUPPLEMENTATION; ADENOMA; ANALYSIS; CALCIUM INTAKE; COLORECTAL NEOPLASMS; DIETARY SUPPLEMENT; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; INTESTINE MUCOSA; MIDDLE AGED; PATHOLOGY; RECTUM; THERAPEUTIC USE;

ADENOMA; AGED; ANTICARCINOGENIC AGENTS; CALCIUM, DIETARY; CHOLECALCIFEROL; COLORECTAL NEOPLASMS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MIDDLE AGED; RECTUM; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTORS;

EID: 84924759842     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22096     Document Type: Article

References (52)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61:212-236.
2. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-767.
3. Chan AT, Giovannucci EL. Primary prevention of colorectal cancer. Gastroenterology 2010; 138:2029-2043.
4. Huncharek M, Muscat J, Kupelnick B. Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: A meta-analysis of 26, 335 cases from 60 observational studies. Nutr Cancer 2009; 61:47-69.
5. Weingarten MA, Zalmanovici A, Yaphe J. Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps. Cochrane Database Syst Rev 2005; 3:CD003548.
6. Ma Y, Zhang P, Wang F, Yang J, Liu Z, Qin H. Association between vitamin D and risk of colorectal cancer: A systematic review of prospective studies. J Clin Oncol 2011; 29:3775-3782.
7. Wei MY, Garland CF, Gorham ED, Mohr SB, Giovannucci E. Vitamin D and prevention of colorectal adenoma: A meta-analysis. Cancer Epidemiol Biomarkers Prev 2008; 17:2958-2969.
8. Bostick RM, Goodman M, Sidelnikov E. Calcium Vitamin D. In: Potter JD, Lindor NM, editors. Genetics of colorectal cancer. New York: Springer; 2009. pp. 277-298.
9. Ahearn TU, McCullough ML, Flanders WD, et al. A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on markers of their metabolism in normal mucosa of colorectal adenoma patients. Cancer Res 2011; 71:413-423.
10. Fedirko V, Bostick RM, Flanders WD, et al. Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: A randomized, double-blind, placebo-controlled clinical trial. Cancer Prev Res (Phila) 2009; 2:213-223.
11. Fedirko V, Bostick RM, Flanders WD, et al. Effects of vitamin d and calcium on proliferation and differentiation in normal colon mucosa: A randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2009; 18:2933-2941.
12. Fedirko V, Bostick RM, Long Q, et al. Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: A randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2010; 19:280-291.
13. Sidelnikov E, Bostick RM, Flanders WD, et al. Effects of calcium and vitamin D on MLH1 and MSH2 expression in rectal mucosa of sporadic colorectal adenoma patients. Cancer Epidemiol Biomarkers Prev 2010; 19:1022-1032.
14. Hopkins MH, Owen J, Ahearn T, et al. Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: A randomized, controlled clinical trial. Cancer Prev Res (Phila) 2011; 4:1645-1654.
15. Ahearn TU, Shaukat A, Flanders WD, Rutherford RE, Bostick RM. A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on the APC/beta-catenin pathway in the normal mucosa of colorectal adenoma patients. Cancer Prev Res (Phila) 2012; 5:1247-1256.
16. Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2010; 141:1117-1134.
17. Ikushima H, Miyazono K. TGFbeta signalling: A complex web in cancer progression. Nat Rev Cancer 2010; 10:415-424.
18. Potter JD. Colorectal cancer: Molecules and populations. J Natl Cancer Inst 1999; 91:916-932.
19. Willett WC, Sampson L, Browne ML, et al. The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol 1988; 127:188-199.
20. Lipkin M, Bell B, Sherlock P. Cell proliferation kinetics in the gastrointestinal tract of man. I. Cell renewal in colon and rectum. J Clin Invest 1963; 42:767-776.
21. Bostick RM, Fosdick L, Wood JR, et al. Calcium and colorectal epithelial cell proliferation in sporadic adenoma patients: A randomized, double-blinded, placebo-controlled clinical trial. J Natl Cancer Inst 1995; 87:1307-1315.
22. Bostick RM. Diet and nutrition in the etiology and primary prevention of colon cancer. In: Bendich A, Deckelbaum RJ, editors. Preventive nutrition: The comprehensive guide for health professionals. Totowa: Humana Press; 2001. p 47-96.
23. Scalmati A, Roncucci L, Ghidini G, Biasco G, Ponz de Leon M. Epithelial cell kinetics in the remaining colorectal mucosa after surgery for cancer of the large bowel. Cancer Res 1990; 50:7937-7941.
24. Anti M, Marra G, Armelao F, et al. Rectal epithelial cell proliferation patterns as predictors of adenomatous colorectal polyp recurrence. Gut 1993; 34:525-530.
25. Cameron IL, Hardman WE. Paracrine action of transforming growth factor-alpha in rectal crypt epithelium of humans. Cell Biol Int 2002; 26:1029-1034.
26. Hardman WE, Cameron IL, Beer WH, Speeg KV, Kadakia SC, Lang KA. Transforming growth factor alpha distribution in rectal crypts as a biomarker of decreased colon cancer risk in patients consuming cellulose. Cancer Epidemiol Biomarkers Prev 1997; 6:633-637.
27. Thomas DM, Nasim MM, Gullick WJ, Alison MR. Immunoreactivity of transforming growth factor alpha in the normal adult gastrointestinal tract. Gut 1992; 33:628-631.
28. Daniel CR, Bostick RM, Flanders WD, et al. TGF-alpha expression as a potential biomarker of risk within the normal-appearing colorectal mucosa of patients with and without incident sporadic adenoma. Cancer Epidemiol Biomarkers Prev 2009; 18:65-73.
29. Tanaka S, Imanishi K, Haruma K, et al. Immunoreactive transforming growth factor-alpha and epidermal growth factor in colorectal adenomas and carcinomas. Oncology 1992; 49:381-385.
30. Liu C, Woo A, Tsao MS. Expression of transforming growth factor-alpha in primary human colon and lung carcinomas. Br J Cancer 1990; 62:425-429.
31. Shim KS, Kim KH, Park BW, et al. Increased serum levels of transforming growth factor-alpha in patients with colorectal cancer. Dis Colon Rectum 1998; 41:219-224.
32. Moskal TL, Huang S, Ellis LM, Fritsche HA, Jr., Chakrabarty S. Serum levels of transforming growth factor alpha in gastrointestinal cancer patients. Cancer Epidemiol Biomarkers Prev 1995; 4:127-131.
33. Lipkin M, Friedman E, Winawer SJ, Newmark H. Colonic epithelial cell proliferation in responders and nonresponders to supplemental dietary calcium. Cancer Res 1989; 49:248-254.
34. Cats A, Kleibeuker JH, van der Meer R, et al. Randomized, double-blinded, placebo-controlled intervention study with supplemental calcium in families with hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst 1995; 87:598-603.
35. Shih IM, Wang TL, Traverso G, et al. Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci USA 2001; 98:2640-2645.
36. Richter M, Jurek D, Wrba F, et al. Cells obtained from colorectal microadenomas mirror early premalignant growth patterns in vitro. Eur J Cancer 2002; 38:1937-1945.
37. Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 1999; 340:101-107.
38. Barnes CJ, Hamby-Mason RL, Hardman WE, Cameron IL, Speeg KV, Lee M. Effect of aspirin on prostaglandin E2 formation and transforming growth factor alpha expression in human rectal mucosa from individuals with a history of adenomatous polyps of the colon. Cancer Epidemiol Biomarkers Prev 1999; 8:311-315.
39. Mendelsohn J, Baird A, Fan Z, Markowitz SD. Growth factors and their receptors in epithelial malignancies. In: Mendelsohn J, Howley PM, Israel MA, Liotta L, editors. The molecular basis of cancer, 2nd edition. Philadelphia, PA: WB Saunders Co; 2001. pp. 137-161.
40. Achyut BR, Yang L. Transforming growth factor-beta in the gastrointestinal and hepatic tumor microenvironment. Gastroenterology 2011; 141:1167-1178.
41. Engle SJ, Hoying JB, Boivin GP, Ormsby I, Gartside PS, Doetschman T. Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. Cancer Res 1999; 59:3379-3386.
42. Joiakim AP, Chopra DP. Retinoic acid and calcium regulation of p53, transforming growth factor-beta 1, and transforming growth factor-alpha gene expression and growth in adenovirus 12-SV40-transformed human tracheal gland epithelial cells. Am J Respir Cell Mol Biol 1993; 8:408-416.
43. Koli K, Keski-Oja J. 1, 25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells. Cancer Res 1995; 55:1540-1546.
44. Danielpour D. Induction of transforming growth factor-beta autocrine activity by all-trans-retinoic acid and 1 alpha, 25-dihydroxyvitamin D3 in NRP-152 rat prostatic epithelial cells. J Cell Physiol 1996; 166:231-239.
45. Cantorna MT, Woodward WD, Hayes CE, DeLuca HF. 1, 25- dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. J Immunol 1998; 160:5314-5319.
46. Bizzarri M, Cucina A, Valente MG, et al. Melatonin and vitamin D3 increase TGF-beta1 release and induce growth inhibition in breast cancer cell cultures. J Surg Res 2003; 110:332-337.
47. Mahon BD, Gordon SA, Cruz J, Cosman F, Cantorna MT. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 2003; 134:128-132.
48. Wu Y, Craig TA, Lutz WH, Kumar R. Identification of 1 alpha, 25-dihydroxyvitamin D3 response elements in the human transforming growth factor beta 2 gene. Biochemistry 1999; 38:2654-2660.
49. Takeshita A, Imai K, Kato S, Kitano S, Hanazawa S. 1alpha, 25-dehydroxyvitamin D3 synergism toward transforming growth factor-beta1-induced AP-1 transcriptional activity in mouse osteoblastic cells via its nuclear receptor. J Biol Chem 1998; 273:14738-14744.
50. Kim SJ, Angel P, Lafyatis R, et al. Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol Cell Biol 1990; 10:1492-1497.
51. Terpstra OT, van Blankenstein M, Dees J, Eilers GA. Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology 1987; 92:704-708.
52. Potten CS, Kellett M, Roberts SA, Rew DA, Wilson GD. Measurement of in vivo proliferation in human colorectal mucosa using bromodeoxyuridine. Gut 1992; 33:71-78.